Columbia Care Inc. (CCHW.CN)

0.6900 -0.0500 (-6.76%) At close: 03:07PM EDT

Columbia Care Inc.

680 Fifth Avenue
24th Floor
New York, NY 10019
United States
212 634 7100
https://columbia.care

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Nicholas Keane Vita	Co-Founder, CEO & Director	846.88k	N/A	1973
Mr. David J. Hart	Chief Operating Officer	510.54k	N/A	1977
Mr. Derek Watson	Chief Financial Officer	N/A	N/A	1971
Dr. Rosemary Mazanet M.D., Ph.D.	Chief Scientific Officer	N/A	N/A	1956
Mr. Bryan Lamont Olson	Chief People & Admin. Officer	N/A	N/A	1974
Ms. Lee Ann Evans	VP of Investor Relations	N/A	N/A	N/A
Kate Driscoll	VP of Compliance	N/A	N/A	N/A
Mr. David Sirolly	Chief Legal Officer & Gen. Counsel	N/A	N/A	1975
Mr. Bryant Ison	Chief Marketing Officer	N/A	N/A	N/A
Mr. Guy Jacques Hussussian	Chief Data Officer	N/A	N/A	1967

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Columbia Care Inc. engages in cultivation, manufacture, and provision of cannabis products and related services in the United States and internationally. The company offers spanning flower, edibles, oils, and tablets under the Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber brand names. It holds licenses in 17 jurisdictions in the United States. The company was founded in 2012 and is headquartered in New York, New York.

Corporate Governance

Columbia Care Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.